Revenue ($USD): $6,618,266,241
Revenue (foreign currencies): JP¥870,030,000,000
R&D spend: $509,649,784.00
Employees: 22,756
Fiscal year end: 03/31/23
CEO: Stefan Kaufmann, president and CEO; Gabriela Kaynor, therapeutic solutions global division head; Frank Drewalowski, endoscopic solutions global division head; Richard Reynolds, president, Medical Systems Group, Olympus Corporation of the Americas
On the positive side, Olympusplanned to establish a series of digital excellence centersfollowing its acquisition of London-based Odin Vision and its cloud AI-enabled applications for endoscopy. Olympus also recentlylaunched its next-gen EasySuite ES-IP systemfor procedure room visualization and integration in the U.S.
Olympus medical devices primarily serve gastroenterology, general surgery, pulmonology, bronchoscopy, urology, gynecology, otolaryngology, bariatrics, orthopedics and anesthesiology.–CN